Status:
NOT_YET_RECRUITING
Pleurodesis in Small-bore Chest Tube
Lead Sponsor:
The University of Hong Kong
Conditions:
Pleural Effusion, Malignant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Malignant pleural effusion (MPE) imposes a high burden on the healthcare system in the Asian Pacific region, as lung and breast cancer are the commonest cancers associated with malignant pleural effus...
Detailed Description
Chest tubes can be classified as large bore or small-bore base on the size, with commonly ≤14 French (Fr) was defined as small-bore and \>14 Fr was defined as large bore. Small-bore chest tubes are in...
Eligibility Criteria
Inclusion
- Pleural effusion.
- With clinical indications for pleural drainage and chest drain insertion.
- With anticipated need for pleurodesis e.g. known malignancy, no clinical signs of pleural infection.
- age ≥18 year-old
Exclusion
- Pleural effusion not sizable for drainage.
- With clinical suspicion of pleural infection e.g. pleuritic chest pain, fever, ultrasound showed loculated pleural effusion
- Age ≤18 year-old
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2029
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07208409
Start Date
February 1 2026
End Date
January 31 2029
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong, Queen Mary Hospital
Hong Kong, China